Philipp Königshofer

5PUBLICATIONS
16CO-AUTHORS
Molecular targetsFluid-structure interaction and aeroacousticsCell physiologyProteins and peptidesRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 21, 2024
Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosis.

Benedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer

|Oct 30, 2021
Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies.

Philipp Königshofer, Benedikt Silvester Hofer, Ksenia Brusilovskaya

|Sep 04, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.

Ksenia Brusilovskaya, Philipp Königshofer, Daniel Lampach

|Jun 21, 2018
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.

Philipp Schwabl, Ksenia Brusilovskaya, Paul Supper

Pageof 1